HUP0302522A2 - Ivabradint tartalmazó szabályozott felszabadulású, szilárd, hőre formázható gyógyszerkészítmény - Google Patents
Ivabradint tartalmazó szabályozott felszabadulású, szilárd, hőre formázható gyógyszerkészítményInfo
- Publication number
- HUP0302522A2 HUP0302522A2 HU0302522A HUP0302522A HUP0302522A2 HU P0302522 A2 HUP0302522 A2 HU P0302522A2 HU 0302522 A HU0302522 A HU 0302522A HU P0302522 A HUP0302522 A HU P0302522A HU P0302522 A2 HUP0302522 A2 HU P0302522A2
- Authority
- HU
- Hungary
- Prior art keywords
- ivabradine
- solid pharmaceutical
- controlled release
- controlled
- release
- Prior art date
Links
- ACRHBAYQBXXRTO-OAQYLSRUSA-N ivabradine Chemical compound C1CC2=CC(OC)=C(OC)C=C2CC(=O)N1CCCN(C)C[C@H]1CC2=C1C=C(OC)C(OC)=C2 ACRHBAYQBXXRTO-OAQYLSRUSA-N 0.000 title abstract 4
- 229960003825 ivabradine Drugs 0.000 title abstract 4
- 239000007787 solid Substances 0.000 title abstract 3
- 238000013270 controlled release Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000001125 extrusion Methods 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 229920000193 polymethacrylate Polymers 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000003405 delayed action preparation Substances 0.000 abstract 1
- 238000005516 engineering process Methods 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000001746 injection moulding Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A találmány tárgya szilárd gyógyszerkészítmény ivabradin vagygyógyszerészetileg elfogadható sója szabályozott felszabadulásánakbiztosítására, amely ivabradin vagy gyógyszerészetileg elfogadhatósója és egy vagy több, a polimetakrilátok csoportjába tartozó polimerhőformázható keverékét tartalmazza és az ivabradin felszabadulása csakaz alkalmazott polimetakrilátok természetével, a polimerekivarbardinhoz hasonlitott relatív mennyiségével és a készítményelőállítási technológiájával van szabályozva. A találmány szerintiszilárd, szabályozott felszabadulású készítményeket extrudálással, ko-extrudálással, fröccsöntéssel, vagy ko-fröccsöntéssel állítják elő ésa készítmények alkalmasak orális, bukkális, nyelv alatti, okuláris,vaginális, rektális vagy parenterális adagolásra. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0017015A FR2818552B1 (fr) | 2000-12-26 | 2000-12-26 | Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine |
PCT/FR2001/004134 WO2002051387A1 (fr) | 2000-12-26 | 2001-12-21 | Composition pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP0302522A2 true HUP0302522A2 (hu) | 2003-12-29 |
HUP0302522A3 HUP0302522A3 (en) | 2007-09-28 |
HU229410B1 HU229410B1 (en) | 2013-12-30 |
Family
ID=8858190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0302522A HU229410B1 (en) | 2000-12-26 | 2001-12-21 | Ivabradine containing solid thermoformed pharmaceutical composition for controlled release |
Country Status (27)
Country | Link |
---|---|
US (1) | US20040028743A1 (hu) |
EP (1) | EP1345594B1 (hu) |
JP (2) | JP2004518665A (hu) |
KR (1) | KR100542472B1 (hu) |
CN (1) | CN1203844C (hu) |
AT (1) | ATE352290T1 (hu) |
AU (1) | AU2002228119B2 (hu) |
BR (1) | BR0116548A (hu) |
CA (1) | CA2432645A1 (hu) |
CY (1) | CY1106390T1 (hu) |
CZ (1) | CZ304587B6 (hu) |
DE (1) | DE60126332T2 (hu) |
DK (1) | DK1345594T3 (hu) |
EA (1) | EA005814B1 (hu) |
ES (1) | ES2280420T3 (hu) |
FR (1) | FR2818552B1 (hu) |
HK (1) | HK1060514A1 (hu) |
HU (1) | HU229410B1 (hu) |
MX (1) | MXPA03005840A (hu) |
NO (1) | NO333776B1 (hu) |
NZ (1) | NZ526406A (hu) |
PL (1) | PL203835B1 (hu) |
PT (1) | PT1345594E (hu) |
SI (1) | SI1345594T1 (hu) |
SK (1) | SK286413B6 (hu) |
WO (1) | WO2002051387A1 (hu) |
ZA (1) | ZA200304441B (hu) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2818552B1 (fr) * | 2000-12-26 | 2003-02-07 | Servier Lab | Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine |
FR2834896B1 (fr) * | 2002-01-23 | 2004-02-27 | Servier Lab | Composition pharmaceutique orodispersible d'ivabradine |
TWI357815B (en) * | 2003-06-27 | 2012-02-11 | Euro Celtique Sa | Multiparticulates |
US20060165790A1 (en) * | 2003-06-27 | 2006-07-27 | Malcolm Walden | Multiparticulates |
GB2418854B (en) | 2004-08-31 | 2009-12-23 | Euro Celtique Sa | Multiparticulates |
FR2882556B1 (fr) | 2005-02-28 | 2007-05-04 | Servier Lab | Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
FR2882553B1 (fr) | 2005-02-28 | 2007-05-04 | Servier Lab | Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
WO2010128525A2 (en) * | 2009-05-04 | 2010-11-11 | Dinesh Shantilal Patel | A formulation of ivabradine for treating the cardiovascular disease |
PL2579859T3 (pl) | 2010-06-14 | 2015-12-31 | Ratiopharm Gmbh | Kompozycja stała zawierająca iwabradynę |
CN101897682B (zh) * | 2010-07-13 | 2012-02-15 | 石药集团欧意药业有限公司 | 一种伊伐布雷定或其可药用盐固体制剂及其制备方法 |
CN102908327B (zh) * | 2011-08-05 | 2015-03-11 | 江苏恒瑞医药股份有限公司 | 伊伐布雷定或其可药用盐的缓释制剂 |
WO2015091992A1 (en) * | 2013-12-20 | 2015-06-25 | Synthon B.V. | Pharmaceutical composition comprising amorphous ivabradine |
EP3025705B8 (en) | 2014-11-25 | 2018-11-28 | Sanofi Ilaç Sanayi ve Ticaret Anonim Sirketi | Stable ivabradine formulations |
CN104398486B (zh) * | 2014-12-08 | 2018-01-12 | 武汉武药科技有限公司 | 一种盐酸伊伐布雷定渗透泵控释片及其制备方法 |
EP3366282A1 (en) | 2017-02-28 | 2018-08-29 | Sanovel Ilac Sanayi ve Ticaret A.S. | Solid oral pharmaceutical compositions of ivabradine |
KR20190001340A (ko) * | 2017-06-27 | 2019-01-04 | 에리슨제약(주) | 이바브라딘을 포함하는 서방성 약제학적 조성물 및 이의 제조방법 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2681862B1 (fr) * | 1991-09-27 | 1993-11-12 | Adir Cie | Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent. |
DE4138513A1 (de) * | 1991-11-23 | 1993-05-27 | Basf Ag | Feste pharmazeutische retardform |
US5879705A (en) * | 1993-07-27 | 1999-03-09 | Euro-Celtique S.A. | Sustained release compositions of morphine and a method of preparing pharmaceutical compositions |
US5965161A (en) * | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
CA2231050A1 (en) * | 1995-09-07 | 1997-03-13 | Biovail International Ltd. | System for rendering substantially non-dissoluble bio-affecting agents bio-available |
AU725811B2 (en) * | 1997-08-26 | 2000-10-19 | Aventisub Llc | Pharmaceutical composition for combination of piperidinoalkanol-decongestant |
US6673367B1 (en) * | 1998-12-17 | 2004-01-06 | Euro-Celtique, S.A. | Controlled/modified release oral methylphenidate formulations |
DE19901040A1 (de) * | 1999-01-14 | 2000-07-20 | Knoll Ag | Arzneiformen mit gesteuerter Freisetzung, enthaltend gut wasserlösliche Wirkstoffe |
FR2795326B1 (fr) * | 1999-06-28 | 2001-08-31 | Adir | Composition pharmaceutique solide thermoformable a liberation controlee |
UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
FR2818552B1 (fr) * | 2000-12-26 | 2003-02-07 | Servier Lab | Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine |
-
2000
- 2000-12-26 FR FR0017015A patent/FR2818552B1/fr not_active Expired - Fee Related
-
2001
- 2001-12-21 SI SI200130697T patent/SI1345594T1/sl unknown
- 2001-12-21 AT AT01989654T patent/ATE352290T1/de active
- 2001-12-21 PT PT01989654T patent/PT1345594E/pt unknown
- 2001-12-21 JP JP2002552533A patent/JP2004518665A/ja active Pending
- 2001-12-21 DK DK01989654T patent/DK1345594T3/da active
- 2001-12-21 BR BR0116548-8A patent/BR0116548A/pt not_active Application Discontinuation
- 2001-12-21 CA CA002432645A patent/CA2432645A1/fr not_active Withdrawn
- 2001-12-21 KR KR1020037008654A patent/KR100542472B1/ko not_active IP Right Cessation
- 2001-12-21 CZ CZ2003-2020A patent/CZ304587B6/cs not_active IP Right Cessation
- 2001-12-21 WO PCT/FR2001/004134 patent/WO2002051387A1/fr active IP Right Grant
- 2001-12-21 HU HU0302522A patent/HU229410B1/hu not_active IP Right Cessation
- 2001-12-21 AU AU2002228119A patent/AU2002228119B2/en not_active Ceased
- 2001-12-21 DE DE60126332T patent/DE60126332T2/de not_active Expired - Lifetime
- 2001-12-21 ES ES01989654T patent/ES2280420T3/es not_active Expired - Lifetime
- 2001-12-21 EP EP01989654A patent/EP1345594B1/fr not_active Expired - Lifetime
- 2001-12-21 SK SK942-2003A patent/SK286413B6/sk not_active IP Right Cessation
- 2001-12-21 PL PL361662A patent/PL203835B1/pl unknown
- 2001-12-21 CN CNB018213677A patent/CN1203844C/zh not_active Expired - Fee Related
- 2001-12-21 US US10/451,903 patent/US20040028743A1/en not_active Abandoned
- 2001-12-21 MX MXPA03005840A patent/MXPA03005840A/es active IP Right Grant
- 2001-12-21 NZ NZ526406A patent/NZ526406A/en not_active IP Right Cessation
- 2001-12-21 EA EA200300667A patent/EA005814B1/ru not_active IP Right Cessation
-
2003
- 2003-06-06 ZA ZA200304441A patent/ZA200304441B/en unknown
- 2003-06-16 NO NO20032737A patent/NO333776B1/no not_active IP Right Cessation
-
2004
- 2004-05-17 HK HK04103476A patent/HK1060514A1/xx not_active IP Right Cessation
-
2007
- 2007-03-16 CY CY20071100370T patent/CY1106390T1/el unknown
-
2009
- 2009-12-25 JP JP2009295406A patent/JP2010100641A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0302522A2 (hu) | Ivabradint tartalmazó szabályozott felszabadulású, szilárd, hőre formázható gyógyszerkészítmény | |
BR0002880A (pt) | Composição farmacêutica de liberação controlada termoformável sólida | |
PT1309315E (pt) | Formulacao oral de desintegracao rapida de valdecoxib | |
EP1120109A3 (en) | Rapidly disintegrating and fast dissolving solid dosage form | |
BG102438A (en) | Medicamentous form | |
ATE288259T1 (de) | Verfahren zur herstellung fester oraler darreichungsformen mit retardierender wirkstofffreisetzung | |
BR0206695A (pt) | Formas de dosagem de epotilonas para administração oral | |
EP1348429A3 (en) | Melt-extruded orally administrable opioid formulations | |
HUP0203257A2 (hu) | Atorvastatin kalcium polimorf módosulatai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
EP1138321A3 (de) | Feste orale Darreichungsformen mit retardierter Wirkstoffreisetzung und hoher mechanischer Stabilität | |
BR0014271A (pt) | Composições antivirais | |
HUP0002316A2 (hu) | Gyorsan olvadó orális adagolási formák | |
HUP0203451A2 (hu) | Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra | |
HUP0004133A2 (hu) | Progesztin és polikarboxilsav kombinált alkalmazása ciklusszabályozásra alkalmas gyógyszerkészítmények előállítására | |
TW200635617A (en) | Multiparticulate pharmaceutical form comprising mucoadhesively formulated nucleic acid active ingredients, and a process for producing the pharmaceutical form | |
WO2004019901A3 (en) | Sustained release pharmaceutical composition | |
GR1003658B (el) | Δισκιο μητρας που καθιστα δυνατη την παρατεταμενη απελευθερωση της τριμεταζιδινης μετα χορηγηση δια της στοματικης οδου | |
ATE226450T1 (de) | Gepufferte orthoesterpolymere enthaltende arzneimittel | |
AU4903700A (en) | Chronotherapeutic diltiazem formulations and the administration thereof | |
IT1255792B (it) | Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda | |
HUP0301390A2 (hu) | Valzartánt tartalmazó orális gyógyászati készítmény | |
HUP0302524A2 (hu) | Perindoprilt tartalmazó szilárd, szabályozott felszabadulású, hőformázással nyert gyógyszerkészítmény | |
RU2003105812A (ru) | Композиции и дозируемые формы, предназначенные для применения в полости рта с целью лечения микозов | |
DE68909100D1 (de) | Physiologisch wirkende Substanzen, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen davon. | |
AR020998A1 (es) | Formulaciones de liberacion controlada de metamizol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of definitive patent protection due to non-payment of fees |